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Calcium (Cav1 andCav2) and sodium channels possess homo-
logous CaM-binding motifs, known as IQ motifs in their C ter-
mini, which associate with calmodulin (CaM), a universal cal-
cium sensor. Cav3 T-type channels, which serve as pacemakers
of the mammalian brain and heart, lack a C-terminal IQ motif.
We illustrate that T-type channels associate with CaM using
co-immunoprecipitation experiments and single particle cryo-
electronmicroscopy.We demonstrate that protostome inverte-
brate (LCav3) and human Cav3.1, Cav3.2, and Cav3.3 T-type
channels specifically associate with CaM at helix 2 of the gating
brake in the I–II linker of the channels. Isothermal titration cal-
orimetry results revealed that the gating brake and CaM bind
each other with high-nanomolar affinity. We show that the gat-
ing brake assumes a helical conformation upon binding CaM,
with associated conformational changes to both CaM lobes as
indicated by amide chemical shifts of the amino acids of CaM in
1H-15N HSQC NMR spectra. Intact Ca2-binding sites on CaM
and an intact gating brake sequence (first 39 amino acids of the
I–II linker) were required inCav3.2 channels to prevent the run-
away gating phenotype, a hyperpolarizing shift in voltage sensi-
tivities and faster gating kinetics.We conclude that the presence
of high-nanomolar affinity binding sites for CaM at its universal
gating brake and its unique form of regulation via the tuning of
the voltage range of activity could influence the participation of
Cav3 T-type channels in heart and brain rhythms. Our findings
may have implications for arrhythmia disorders arising from
mutations in the gating brake or CaM.
Calmodulin (CaM)3 is a universal resident calcium sensor
that promotes a calcium-dependent regulation at a canonical
IQ motif of the C-terminal tails of voltage-gated calcium chan-
nels (1–5) and sodium channels (6). CaM regulates a rapid
and robust inactivation gating of L-type calcium channels (e.g.
Cav1.2) (7) or skeletal muscle sodium channels (e.g.Nav1.4) (2)
and a facilitation of channel currents in synaptic (e.g. Cav2.1)
calcium channels (8). The conservation of CaM binding
extends to basal Cav1 L-type channels in single-celled
eukaryotes, such as ciliate Paramecium tetraurelia, which has
an extended C terminus that includes a conserved IQmotif (9).
CaM mutants of Paramecium (10) influence the calcium-de-
pendent inactivation of L-type calcium currents (11, 12) and
their control of ciliary beat frequency for swimming and turn-
ing behavior (13). CaM binding at the IQ motif and its con-
served regulation are consistent with the observed calcium-
dependent inactivation (known as CDI) even in expressed
cnidarian L-type channel homolog (14). All vertebrate L-type
channels display a calcium-dependent inactivation that ranges
fromminor to very robust, fromCav1.4 to Cav1.1 to Cav1.2 and
Cav1.3 channels, respectively (15). A hallmark of the calcium-
dependent inactivation in L-type calcium channels is its resil-
ience even in the presence of high-calcium buffering in 10 mM
EGTA or BAPTA. This resilience in calcium sensing in the
presence of high-calcium buffering is conferred by a secondary
CaM-binding site referred to as NSCaTE (N-terminal spatial
Ca2-transforming element) specifically contained within the
N terminus of invertebrate Cav1 channels (9) and mammalian
Cav1.2 and Cav1.3 channels (16, 17). NSCaTE is lacking outside
of L-type calcium channels, but the highly conserved C-terminal
IQmotif extends tomembers of the sodium channel family, from
Nav2 channels in the early branching single-celled eukaryotes
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before the split of animals and fungi, suchas apusozoan,Thecamo-
nas trahens, and Nav1 channels (18), including cnidarian jellyfish,
which are the extant relatives of the likely ancestors containing the
first metazoan nervous systems (19, 20). The only member of the
calcium and sodium channel superfamily to lack the reported
CaM-bindingelements (theC-terminal IQmotif and theN-termi-
nal NSCaTE) are Cav3 T-type channels (1, 2, 21).
Here, we show that Cav3 T-type channels possess high-affinity
calmodulinbindingat the“gatingbrake,” ahelix–loop–helixmotif
located in the proximal I–II linker of knownCav3T-type channels
in the analogous positionwhere accessory Cav subunits regulate
Cav1 andCav2 channel complexes (22). This gating brake governs
the low-voltage dependence of T-type channels, and its absence
generates a “runaway gating” phenotype (23–26). Mutations that
alter the function of the Cav3.2 gating brake have been found in
human patients with absence epilepsy (27, 28).
CaM-binding sequences are variable, which can range from a
striking likeness to theC-terminal IQmotif fromL-type channels,
as in the gating brake of the basal metazoan Trichoplax adherens,
to diverse sequences that generate a nanomolar affinity for CaM
binding in protostome invertebrates such as pond snail LCav3 and
all human (Cav3.1, Cav3.2 , and Cav3.3) channel isoforms. We
demonstrate thatCaMfacilitates the formationof-helices ingat-
ing brake sequences, can pre-associate with Cav3 T-type channels
without calcium ions, and its binding involves structural confor-
mational changes in both N- and C-terminal pairs of EF hands in
CaM and the gating brake. Dialysis of CaM binding (CaMB) pep-
tides, or co-expression of apo-CaM (CaM1234) generates a signifi-
cant hyper-polarizing shift in voltage sensitivities and faster gating
kinetics, consistent with the mutant phenotype of Cav3 T-type
channels lacking a gating brake in the I–II linker.
Cav3 T-type channels contribute to pacemaker rhythms,
such as the conducting system of the heart (29) and low-thresh-
old calcium potentials (also known as low-threshold spikes),
that trigger rhythmic burst firing classically associated
with thalamic neurons during non-rapid eye movement sleep
and to the spike wave discharge during absence seizures (30,
31). There is also significant evidence for T-type currents partici-
pating in “low threshold” neurotransmitter release (32) and in the
maintenance of vascular tone (33). Cav3T-type channels possess a
significant “window current” that provides a small but continuous
stream of calcium influx through a population of Cav3 T-type
channels open at rest (34). This calcium, available through Cav3
T-type channels at rest, ismodeled to contribute to cellular prolif-
erationduring organdevelopment, to the aberrant proliferation in
many cancers (35), and to the hypertrophied condition of the
mammalian heart (36). Classically, Cav3 T-type channels are
mostly inactivated at rest, and their participation rate is steeply
voltage-dependent (37). CaM’s regulation of the voltage sensitivi-
ties of Cav3 T-type channels at the gating brake thus has dramatic
consequences to the participation ofCav3T-type channels in nor-
mal functions, as well as during development and disease.
Results
CaM complexes with full-length Cav3 T-type channels
Full-length mammalian Cav3.1 channels were purified from
Sf9 insect cells (38) and co-incubated with biotin–CaM com-
plexed to a streptavidin–gold conjugate. Fig. 1A (left panel)
shows a field of purified Cav3.1 (protein appearswhite) coupled
to an electron dense (black) gold particle, indicating CaM is
bound. Individual images illustrating different orientations of
the single particles of Cav3.1 channels alone or calmodulin–
gold alone and Cav3.1 channels in complex with calmodulin–
gold are shown in montages of viewpoints on top, bottom, and
middle panels, respectively, in Fig. 1A. The orientation of the
channel in some images allows identification of the C terminus,
a protruding, finger-like projection from the transmembrane
domain of Cav3.1 as highlighted by an asterisk; a feature previ-
ously identified through single-particle electron microscopy
3-D reconstruction of Cav3.1 (38). We confirmed the com-
plexing of calmodulin with Cav3 T-type channels as co-im-
munoprecipitants in Western blottings (see Fig. 1B).
CaM–GFP fusion proteins transfected and purified from
HEK-293T cells and isolated on anti-GFP Sepharose beads
were identified in the complex with HA-tagged Cav3.2 chan-
nels in Western blottings, labeled with anti-HA antibody, as
an 259-kDa band (Fig. 1B, middle lane) in the presence of
calcium ions (33.3 M CaCl2). The co-immunoprecipitation
of CaM–Cav3.2 channels failed in the absence of co-ex-
pressed HA-tagged Cav3.2 channels (Fig. 1B, left lane) or in
the absence of CaM (Fig. 1B, right lane).
Cav3 T-type channels possess a predicted high-affinity
CaM-binding site at their gating brake in the I–II linker
Cav3 T-type channels lack the C-terminal IQ motif shared
among other calcium channels (Cav1 and Cav2) and sodium
(Nav1 and Nav2) channels (1, 2, 21). Because both EM and co-
immunoprecipitation experiments indicated that CaMbinds to
full-length mammalian Cav3.1 and Cav3.2 channels, we there-
fore next sought to delineate the CaM-binding domain. A
unique but ubiquitous feature in Cav3 T-type channels is a
helix–loop–helix, gating brake motif (similar in structure to
a region in fumarase enzyme) in the proximal I–II linker that
is in the analogous position of  subunit binding to Cav1 and
Cav2 calcium channels (25). It is within the second helix of
the gating brake of the I–II cytoplasmic linker where we have
found an analogous region to the C-terminal IQ motif, with
nanomolar affinity binding to CaM (Fig. 2A). Sequence
alignments of Cav3 T-type channels (Fig. 2B) indicated a
predicted CaM-binding site (illustrated by red color gradi-
ent) in helix-2 of the gating brake of representative metazoan
species from cnidarians to the three human Cav3.1, Cav3.2,
and Cav3.3 channels. A CaM-binding site is also predicted in
Cav3 T-type channels by the on-line tool, CaM Target Data-
base (39). Predictions suggest that the gating brake sequence
is cytoplasmic, and a helical wheel analysis indicates its
amphipathic nature.
Cav3 T-type channel frommost basal multicellular animals
resembles the C-terminal IQmotif of Cav1, Cav2, Nav2, and
Nav1 channels
The most basal multicellular organism with a Cav3 T-type
channel is T. adherens (a placozoan) (40), which has a region
spanning the gating brake that is unlike other gating brake
sequences (Fig. 2C, blue bar) with a core 17 amino acids that
Calmodulin at the T-type channel gating brake
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resembles the C-terminal CaM-binding IQmotif of Cav1, Cav2,
andNav2 channels (Fig. 2,C andD, blue bars). The Cav3 T-type
channel in the basal multicellular placozoan may represent a
structural intermediate involving the positioning of the C-ter-
minal IQ motif in the common ancestor to calcium channels
and sodium channels to the proximal I–II linker, before a diver-
gence and appearance of a gating brake helix–loop–helix motif
shared among all other metazoan Cav3 T-type channels. Com-
paratively, the IQmotif of Cav1 L-type channels is mostly iden-
tical frommicrobial eukaryotes to human homologs (9), where
the CaM-binding gating brake motif in Cav3 T-type channels
is more divergent. The protein similarity of gating brake
sequences between protostome invertebrate (e.g. pond snail
LCav3) and among the human Cav3 isoforms is 71–76% (Fig.
2C, red bars). Differences in gating brake sequencesmay reflect
a local adaptability of the gating brake among Cav3 T-type
channels in different animals.
Gating brake peptides from snail LCav3 and the three human
Cav3.1, Cav3.2, and Cav3.3 T-type channels associate with
Ca2–CaM
26-mer peptide sequences spanning the gating brake region
were synthesized for snail LCav3 and human Cav3.1, Cav3.2,
and Cav3.3 channels dubbed “Cav3 CaMB” peptides. In
Figure 1. CaM associates with full-length Cav3 T-type channels illustrated by nano-particle cryoelectron microscopy (A) and co-immunoprecipitation (B). A,
field of negatively stained (2%w/vuranyl acetate) full-lengthCav3.1 in complexwithCaM in thepresenceof 1.5mMCa
2. Scale bar is 50 nm. Left panel,CaMhas
a biotin label that binds streptavidin gold (5 nm). Protein appearswhite, and the gold that is electron-dense is black. Right panel, top row, montage of purified
Cav3.1 particles (white density) presenting different views of the channel. Asterisk indicates “tail” domain that we have previously determined corresponds to
the C terminus (38).Middle row,montage of Cav3.1 particles with CaM–biotin bond indicated by the presence of streptavidin gold (black sphere). Bottom row,
control images of CaM–biotin–streptavidin gold particle without Cav3.1. Observed relative differences in Cav3.1 and streptavidin gold particle sizes relate to
theorientationandcontrast of eachCav3.1 channelparticle adhered to theEMsupport filmand the size variation in the streptavidingoldparticles (3–6nmwith
nominal size of 5 nm, according to the manufacturer). B, CaM–GFP bound to anti-GFP magnetic beads associates with hemagglutinin (HA)-tagged Cav3.2
channel (top panel, middle lane) as illustrated by HA antibody labeling (259-kDa band) of the Cav3.2 channel co-immunoprecipitant (IP) bound to beads.
259-kDaHA-tagged Cav3.2 channel band does not appear as a co-immunoprecipitant in theWestern blot without co-expression of pCDNA3.1 plasmid inserts
containingHA-taggedCav3.2 channel (toppanel, left lane) orwithout co-expressionofCaM–GFP (toppanel, right lane) inHEK-293T cells.Middle panel illustrates
anti-HA antibody staining of the 259-kDa HA-tagged Cav3.2 channel of a replicate experiment of input proteins for the Western blot shown in the top panel
without co-immunoprecipitation. Bottom panel illustrates anti-GFP antibody staining of the 44.2-kDa GFP-tagged CaM or GFP alone (27 kDa), in a replicate
experiment of input proteins for theWesternblot shown in the top panelwithout co-immunoprecipitation.C,CaM–GFP (left two lanes, 44.2 kDa) andGFP alone
(right lane,27 kDa) bound to anti-GFPmagnetic beads as illustratedby anti-GFP antibody labeling (259-kDaband) of theCav3.2 channel co-immunoprecipitant
bound to beads. GFP alone generated two bands on the Western blot, which may result from differing post-translational modifications. Co-immuno-
precipitation experiments were carried out in 33.3 M CaCl2, pH 7.4. Vector for HEK-293T cell expressed inserts for Western blotting (Cav3.2–HA, EGFP,
CaM–pGFP) were contained in pcDNA3.1. Membranes were stained with Ponceau red following protein transfer to evaluate the protein content in each
lane. Co-immunoprecipitation experiments were carried out in 33.3 M CaCl2, pH 7.4. Vector for HEK-293T cell expressed inserts for Western blotting
(Cav3.2–HA, EGFP, CaM–pGFP) were contained in pcDNA3.1. Membranes were stained with Ponceau red following protein transfer to evaluate the
protein content in each lane.
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Figure 2. CaM is predicted to associate with Cav3 T-type channels in helix-2 of the gating brake in the proximal I–II linker. A, illustration of the four
domain (DI, DII, DIII, and DIV) 6 transmembrane helices structure common to sodium channels, calcium channels, and NALCN. Cav1, Cav2, and Nav channels
contain a canonical proximal C-terminal IQmotif that possess high-affinity CaM-binding site. A proposed equivalence of the CaM-binding C-terminal IQmotif
inCav3T-typechannels is ahelix–loop–helixgatingbrakemotif in theproximal I–II linker that is in theanalogouspositionof-subunit binding toCav1andCav2
calcium channels. B, sequence alignment of T-type channels illustrates a predicted CaM-binding site in helix-2 of the gating brake (illustrated by red color) in
representative species from cnidarians to the three human genes. CaM-binding site prediction from CaM Target Database (39). Predictions suggested the
putative CaMB peptide sequence is cytoplasmic, and helical wheel analysis indicates its amphipathic nature. In the most primitive metazoan with a T-type
channel, Trichoplax (placozoan), the most basal extant T-type channel in multicellular organisms known possesses a gating brake motif resembling
the C-terminal IQmotif shared with other calcium (Cav1 and Cav2) and sodium (Nav2 and Nav1) channels (illustrated by blue color). Yellow outlined residues are
the sequences for the synthetic CaMBpeptides. 39 and 111 amino acid sequence deleted in gating brake deletionmutant, Cav3.2(D
453–491) andCav3.2(D
429–539) are
indicated.CandD,proteinsimilaritiesamongCaMBpeptidesequences inthe I–II linker, illustratingthehighsimilarityamonginvertebrate (snail) LCav3andthehuman
Cav3.xhomologs (C) and the greater similarity of TrichoplaxCav3 CaMBpeptide sequences to the C-terminal IQmotif of Cav1.2 channels (D), rather than other gating
brake sequences (C).
Calmodulin at the T-type channel gating brake
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addition, a PGPGPG substituted Cav3.2 channel peptide
(Cav3.2mut) was synthesized, which served as a negative con-
trol peptide in experiments (see yellow highlighted sequence in
Fig. 2B). CaMB peptides promoted a gel-mobility shift with
CaM in the presence of 0.1 mM CaCl2-containing solution and
increasing molar ratios (0.5 to 4) of snail LCav3 or human
Cav3.1, Cav3.2, and Cav3.3 channel CaMB peptides (Fig. 3).
Mutated Cav3.2 CaMB peptide (Cav3.2mut) with the PGPGPG
substitution did not promote a gel-mobility shiftwithCaM(Fig.
3). Cav3.3 peptide has the weakest apparent interaction com-
pared with other Cav3.1 and Cav3.2 peptides, which correlates
with its weaker predicted binding affinity (Fig. 2B). Presence of
urea attenuated the weakest interacting human Cav3.3 chan-
nels with CaM without affecting the higher affinity LCav3 gat-
ing brake peptide with CaM.
Gating brake peptides assume a helical conformation upon
association with Ca2–CaM
Differential circular dichroism (CD) spectroscopy of snail
LCav3, humanCav3.2, andCav3.3 gating brake peptides suggest
that the peptides assume a more helical secondary structure
upon co-incubation with CaM or with helix-stabilizing agent
trifluoroethanol (TFE) (Fig. 4A). Helical propensity of peptides
increases after titrating higher TFE concentrations from 10 to
50% (41, 42). The apparent -helical formation of LCav3 and
Cav3.2 resembles the CD spectral signature with 10% TFE,
whereas Cav3.3 resemblesmore the spectral signaturewith 25%
TFE. Human Cav3.1 is unique among the gating brake pep-
tides in appearing to assume an -helical conformation
when free in solution (without CaM or TFE) (Fig. 4A), and
this can be explained by its high-native alanine content (Fig.
4B). Although the circular dichroism results are suggestive
of induction of helical secondary structure in the peptide
upon binding CaM, some of the observed ellipticity changes
may be induced by tertiary structural changes, not secondary
structural ones (43). Mutated peptide (Cav3.2mut) has no
-helical propensity as predicted due to its proline substitu-
tions (Fig. 4, A and B).
Gating brake peptides bindwith a high nanomolar affinity to
Ca2–CaM
CaM binds Cav3 CaMB peptides in 0.5 mM CaCl2 solution
with a 1:1 stoichiometry, at nanomolar affinities that vary from
12, 43, 187, and 383 nM for snail LCav3, Cav3.1, Cav3.2, and
Cav3.3 CaMB peptides, respectively (representative data in Fig.
5 and table of parameters in Fig. 6A). The rank order of mea-
sured binding affinities determined in the isothermal titration
calorimetry (ITC) (Fig. 6A) is consistent with the rank order of
concentration of CaMB peptide to CaM ratio required for a
saturating gel-mobility shift, 1.0, 1.5, 1.5, and 4.0 for snail
LCav3, Cav3.1, Cav3.2, and Cav3.3 CaMB peptides, respectively
(Fig. 3). The Cav3.3 CaMB peptide possessed the weakest CaM-
binding site of all isoforms as evidenced by the lowestmeasured
affinity with ITC and incomplete gel shift of CaM in native
PAGE (Fig. 3). Besides their variable sequence and binding
affinity differences for CaM, the Cav3 CaMB peptides vary in
their thermodynamic properties during their association with
CaM. The association appears to be entropy-driven for LCav3,
LCav3.1, and Cav3.3 peptides and enthalpy-driven for Cav3.2
peptide, as illustrated by the latter’s negative enthalpy (exother-
mic) (Figs. 5 and 6A).
Gating brake peptides bind and induce structural changes to
both N- and C-terminal lobes of Ca2–CaM andwill likely
associate with CaM in the absence of Ca2
Mutant CaM1234 possess critical Asp3 Ala mutations in its
EF hands that disable Ca2 binding, creating a mutant that
serves as a proxy for apo-CaM (44). The gating brakemay serve
as a pre-association site for binding CaM in the absence of
calcium ions (apo-CaM), with binding of snail LCav3 and
human Cav3.1 CaMB peptides with Ca2-binding deficient
CaM (CaM1234), albeit at an12- and349-fold lower affinity,
respectively, compared with wild-type CaM (Figs. 5 and 6A).
The interactions with CaMB peptides likely involve both lobes
of EF hand pairs of CaM, because both N- and C-terminal CaM
(74-aa constructs spanning exactly half of the CaM molecule)
were able to bindCav3.2 CaMBpeptide, with theN-lobe having
a significantly higher affinity (Figs. 5 and 6A). LCav3 CaMB
peptide will bind to CaMwithmutated N-terminal Ca2-bind-
ing sites (CaM12) but not to CaM with mutated C-terminal
Ca2-binding sites (CaM34) (Fig. 6A). Chemical shift changes
observed in the 1H-15N HSQC NMR spectra of CaM in the
presence of both snail LCav3 (red to cyan color shift, Fig. 6B)
and human Cav3.2 (red to green color shift, Fig. 6B) indicate a
dramatic conformational rearrangement of both N- and
C-terminal lobes of CaM in response to high-affinity binding
to gating brake sequences. The widespread and dramatic
chemical shift differences in Ca2–CaM alone compared
Figure 3. CaMB peptides from snail LCav3 and the three human Cav3.x
T-typechannels associatewithCa2–CaM.Gel-mobility shiftswithCaMare
evident in the presence of 0.1 mM CaCl2-containing solution and increasing
molar ratios (0.5–4) of snail LCav3orhumanCav3.1, Cav3.2, andCav3.3 chan-
nel CaMB peptides but not evident in the presence of mutated control
Cav3.2 CaMB peptide (Cav3.2mut). 1st lane in each gel is Ca
2–CaM-only
control. The rank order of weakest to strongest apparent interaction of
Ca2–CaM for peptides: Cav3.3 Cav3.2 Cav3.1 LCav3 correlates with
the rank order of calculated binding affinities using ITC (see Fig. 5). Note
that Cav3.1 and Cav3.2 peptides both completely displace Ca
2–CaM at
1.5 peptide to CaM molar ratio, but Cav3.1 appears to possess a higher
affinity based on sub-saturation levels of peptide. Urea attenuates the
weaker interacting human Cav3.x channels but does not attenuate the
higher affinity LCav3 CaMB peptide.
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with a CaM–Cav3.2 or CaM–LCav3 CaMB peptide complex
is illustrated in Fig. 6C.
Intracellular dialysis of gating brake peptides, but not
mutated gating brake peptides, causes a hyperpolarizing shift
in voltage dependence and faster gating kinetics in Cav3.2
channels
We tested whether the observed nanomolar affinity of CaM
for the gating brake governs the unique gating properties of
Cav3 T-type channels such as its low voltage of activation. We
challenged cells expressing Cav3.2 T-type channels with 5 M
Cav3.2 CaMB peptides pre-loaded in the intracellular pipette,
and we evaluated the change of gating behavior in whole-cell
patch-clamp recording of transfected Cav3.2 T-type channels
in HEK-293T cells, before and after equilibration of the intra-
cellular dialysis of gating brake peptide (after 15–20 min) (Fig.
7). We conducted parallel control experiments with the
intracellular dialysis of mutant gating brake peptide (Cav3.2
CaMBmut) (mutant sequence in Figs. 2B and 4B). The Cav3
CaMBpeptide challenge toCav3.2 channels causes a phenotype
change, which resembles the 33- or 111-amino acid deletion
mutant phenotype of Cav3 channels lacking the gating brake,
Cav3.2(D453–491) and Cav3.2(D429–539) (23), respectively (Fig.
7). The gating brake is so named because it is considered a
unique regulator of Cav3 T-type channels, maintaining them in
the closed state at resting membrane potentials (23–26), where
disruptions of the gating brake cause the voltage threshold for
activation and inactivation gating to be shifted 20–30mV in the
hyperpolarizing direction (e.g. see Figs. 8 and 9B) (23, 25, 26,
45), with dramatically accelerated activation and inactivation
kinetics (23–26). Activation curves are shifted to negative
potentials by an average of 8 mV (a 50% activation voltage
change from55.28	 1.33 to63.10	 1.29mV) after dialysis
of Cav3.2 CaMB peptide, whereas no corresponding voltage
shifts are observed with mutated CaMB peptides (Cav3.2
CaMBmut) (Fig. 7A). Steady-state inactivation curves of HEK-
293T cell-transfected Cav3.2 channels are also shifted toward
negative potentials by an average of 16 mV (a 50% inactivation
voltage change from83.19	 2.35 mV to99.62	 1.37 mV)
after 20 min of dialysis with Cav3.2 CaMB peptide but not after
dialysis with mutated peptide (Cav3.2 CaMBmut)-treated cells
(Figs. 7B and 8B). Intracellular dialysis of Cav3.2 CaMB peptide
also confers a significant speeding up of channel activation and
inactivation kinetics, compared with Cav3.2 channels dialyzed
with mutated peptide (Cav3.2 CaMBmut). This is quantified as
significant reduction in the  for exponential fits of the kinetics
of activation (Fig. 7A) and inactivation (Fig. 7B) in the presence
of Cav3.2 CaMB peptide.
Dialyzed gating brake peptides specifically target the gating
brake of Cav3.2 channels
We observed that the intracellular dialysis of Cav3.2GB pep-
tide does not confer additional hyperpolarizing shifts in voltage
sensitivity of activation (Fig. 8A) or steady-state inactivation
Figure 4. CaMB peptides from snail Cav3 and human Cav3.x T-type channels assume an -helical structure when bound to Ca
2–CaM. A, differential
circular dichroism (CD) spectra of CaMBpeptides co-incubated in the presence of helix-stabilizing agent, TFE (gray dashed line), 20MCaM (red line), orwithout
CaM(blue line). 26-mer snail LCav3, humanCav3.2, andCav3.3CaMBpeptides (sequence,bottomright) assumeamorehelical secondary structureuponaddition
of CaM and TFE. TFE has a much greater effect on the highest binding affinity peptide, snail LCav3, than the others. Cav3.1 peptide is the only isoform that is
-helical when free in solution, as evidenced by the characteristic negative peaks at 208 and 222 nm. Cav3.2-Gbmut peptide was incapable of adopting an
-helix even at 50% TFE, nor did it appear to interact with CaM. CaM-alone curve was subtracted from each spectra, converted to mean residue ellipticity (),
and smoothed. For TFE experiments, 50M peptide in PBS was used, whereas the baseline was corrected against PBS as background. B, gating brake peptide
sequences highlighting the alanine-rich Cav3.1 sequence in blue outline, and the “PGPGPG” substitution in red outline that serves as the Cav3.2 gating brake
mutant. The 24 residues of the 26-mer peptides with a yellow-colored background are predicted to contain -helices according to PSIPRED version 3.3
(Bioinformatics Group at University College London) (91).
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(Fig. 8B) in Cav3.2 channels possessing the gating brake dele-
tion Cav3.2(D429–539). These observations are consistent with
the specific targeting of Cav3.2 CaMB peptide to helix-2 of the
gating brake region in the I–II linker, a region that possesses a
nanomolar affinity for CaM to promote the observed hyperpo-
larizing shifts in voltage sensitivities of Cav3 T-type channels.
Figure 5. Thermodynamic basis for CaM-bindingpeptide interactionswithwild-type andmutant CaM. Rawdata traces, isothermal titration calorimetry
(above), and integrated heats of the measured interaction were fitted with a One Sites model using Malvern MicroCal (ITC200) add-on within Origin software
(below). A, representative interactions with snail LCav3, and human Cav3.1 and Cav3.2 CaMB peptides and wild-type CaM used in the calculation for their 12.4,
42.7, and 187.1 average nanomolar affinities, respectively. B, sample interactions with human Cav3.2 and Cav3.1 CaMB peptides and mutant calmodulins,
including N-lobe of CaM, and CaM1234 used in the calculation for their 31.1 and 543.3 average nanomolar affinities, respectively. Full table of ITC parameters
(mean	 S.E., n
 3) is illustrated in Fig. 6A.
Figure 6. ITC and NMR analyses indicate high-affinity, nanomolar binding, and associated conformation changes, respectively, upon Cav3 T-type
channel CaM-binding peptides to N- and C-terminal lobes of CaM. A, tabulated data of ITC analysis indicates a 1:1 stoichiometry of CaMbindingwith a 10,
36, 196, and 383 nanomolar affinity for CaM-binding peptides for snail LCav3 and humanCav3.1, Cav3.2, and Cav3.3 channels respectively. All peptide and CaM
interactions are endothermic, exceptCav3.2CaMBpeptide,which is exothermic. LCav3CaMBpeptide inparticular has a complex ITC curve andwill bind toCaM
with mutated N-terminal Ca2-binding sites (CaM12), but not to CaM with mutated C-terminal Ca
2-binding sites (CaM34). N-CaM and C-CaM are 74-aa
constructs (exactly half of the CaMmolecule) representing each individual lobe. BothN- andC-CaMassociatewith Cav3.2 CaMBpeptide, albeit a higher affinity
for theN-lobe of CaM. CaMwith all four Ca2-binding sitesmutated in its lobes (apo-CaM, CaM1234) still associateswith CaM-bindingpeptides. Table headings:
Binding stoichiometry of the interaction between CaM and CaM-binding peptide in solution (N), Binding affinity (Ka), enthalpy changes (H), entropy changes
(S). ITC curves were fitted to a one-set-of-sites model with a high degree of fit for N, Ka, and H values shown for representative experiments in Fig. 5A. The
parameters for the all peptides were calculated from three replicate experiments. B, T-type channel GB peptides promote a conformational change involving
bothCaM lobes confirmedby amide chemical shifts of CaM’s amino acids in 1H-15NHSQCNMR spectra. Overlay of 1H-15NHSQC spectra of CaMalone (red color)
and CaM bound to gating brake peptides from Cav3.2 (green color), or snail LCav3 (cyan color). C, chemical shift differences between CaM and the CaM–Cav3.2
complex and CaM and the CaM–LCav3 complex. B and C illustrate representative data from one of three replicate experiments.
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Results of overexpression experiments withmutated CaM
(CaM1234) strongly suggest that CaM regulates Cav3.2
channels at the gating brake
ITC measurements suggest that the gating brake associates
with bothN- andC-terminal Ca2-binding EF hand pairs. CaM
binds to the gating brake in the absence of viable calcium-bind-
ing sites (CaM1234). This CaM association for Cav3.1 and LCav3
CaMB peptide in the absence of calcium is at an12- or349-
fold reduced affinity, respectively, compared with wild-type
CaM (Fig. 6A). We tested whether calcium occupancy in CaM
lobes is required to prevent the gating brake phenotype. We
overexpressed a plasmid construct coding for CaM1234 to com-
Figure 7. Intracellular dialysis of 5M Cav3 CaMB peptide but not mutated (CaMBmut) peptide causes a hyperpolarization shift and faster channel
kinetics inCav3.2 channels. TransfectedCav3.2 channels inHEK-293T cellswere evaluatedbywhole-cell patch-clampelectrophysiology for activation (A) and
inactivation (B) at start of patch recording (time 0) and after 20 min of intracellular dialysis of 26-mer Cav3 CaM-binding (CaMB) peptide or mutated CaM-
binding (CaMBmut) peptide (peptide sequences in Figs. 2B and 4B). Representative current traces after 20-min dialyses are shown. Calcium currents were
measured for their current-voltage relationships and mono-exponential fits for the kinetics of activation (A) and inactivation (B). Activation and steady-state
inactivation curves were created with peak currents generated from a step depolarization from 110 to 80 to 10 mV and to 30 mV from holding
potentials ranging from140 to40mV, respectively. Statistical significance (p 0.05) using a non-parametric Wilcoxonmatched-pairs signed rank test for
the kinetic data is shown by * measured before and after equilibration of the intracellular dialysis of Cav3 CaMB peptide or mutated CaM binding (CaMBmut)
peptide. n values for current-voltage relationship Cav3 CaMB peptide (n
 7) and CaMBmut (n
 6). n values for inactivation Cav3 CaMB peptide (n
 5) and
CaMBmut (n
 6).
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pete with native CaM (46). The CaM1234 overexpression con-
struct included the bicistronicmarkermRFP (red color fluores-
cent protein) (46) to be used as a visual estimate of the expected
level of CaM1234 overexpression, after mercury lamp excita-
tion with the epifluorescence-inverted microscope used for
patch-clamp recording. TheCaM1234 overexpression construct
also contained two shRNA sequences to knock down CaM
(CALM1,2,3 genes) (46–48). The shRNAknockdown sequences
is reported to be 70% complete in disabling native CaM expres-
sion (46–48). However, knockdown was not effective under
our experimental conditions, as we observed no significant
physiological consequence after transfection of the shRNA
Figure 8. Intracellular dialysis of 5 M Cav3 CaMB peptides cause a hyperpolarizing shift in voltage dependence but only with Cav3.2 channels
containingan intactgatingbrake. Scatterplot (left)withmean	 S.E. (right) values of the voltagesof 50%activation (A) and steady-state inactivation (B) taken
from Boltzmann fits of activation and steady-state inactivation curves for wild-type Cav3.2 channels and Cav3.2 channels with a deleted gating brake (deleted
sequence from429 to539, see Fig. 2A). Representative current traces at time0minandafter 20-mindialysis of Cav3.2CaMBpeptide are shown.Dialysis of CaMB
peptide (after 20 min) generates a hyperpolarizing shift in voltage dependence of wild-type Cav3.2 channels, but it does not promote additional hyperpolar-
izing shifts in voltage dependence on the Cav3.2 channels that are highly hyperpolarizing shifted after gating brake deletion. The statistical significance after
dialyses of CaMB peptide in Cav3.2 channels containing an intact gating brake is p
 0.0156 (*) and p
 0.0313 (*) for V50% activation and V50% inactivation,
respectively, in a Wilcoxon matched-pairs signed rank test.
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CaM knockdown alone. The combined construct of shRNA
knockdown of wild-type CaM and overexpression of CaM1234
had a dominant effect, compared with the overexpression of a
similar construct withwild-typeCaM (Fig. 9). CaM1234 causes a
hyperpolarizing shift in voltage dependence for activation and
inactivation and more rapid gating kinetics (Fig. 9), resembling
the phenotype after saturating CaM-binding sites with dialyzed
gating brake peptides (Figs. 7 and 8) and resembling the run-
away gating phenotype of T-type channels after deletion or
mutation of their gating brake sequences (Fig. 8, A and B) (23–
26). The hyperpolarizing voltage shift conferred by CaM1234
appear to require association with an intact gating brake,
because additional hyper-polarizing shifts in voltage dependence
are lacking in Cav3 channels containing deletion of 39 and 111
amino acids spanning the gating brake, Cav3.2(D453–491) and
Cav3.2(D429–539), respectively (Fig. 9B) (23).
Discussion
Ca2–CaM readily complexes with full-length Cav3 T-type
channels in vitro
We show here that the two most common isoforms of Cav3
T-type channels expressed in both the mammalian brain and
heart (Cav3.1 and Cav3.2) (49), in their full-length configura-
tions, complex with Ca2–CaM in vitro. We illustrate using
electron microscopy that purified full-length Cav3.1 binds
calcium–CaM, data supported by co-immunoprecipitation
experiments. A recent study by Lee et al. reported that a rat
Cav3.3 splice variant co-immunoprecipitates with CaM (50),
adding support for a universality in CaM associating with all
Cav3 T-type channels, in the same manner as CaM serves as a
ubiquitous resident calcium sensor at the C-terminal IQ tails of
Cav1 and Cav2 calcium channels (1–5) and Nav1 sodium chan-
nels (6). Cav3 T-type channels (like all eukaryotic calcium and
sodium channels), are large proteins (250 kDa) that do not
readily express well enough for the purposes of extensive
in vitro biochemical analyses.We chose candidate peptide frag-
ments based on in silico prediction for resolving finer details of
the CaM regulation of Cav3 T-type channels. Examination of
candidate peptides is the standard approach used for other
CaM targets (51).
All known Cav3 T-type channels have a predicted high-affinity
CaM-binding site in helix2 of the helix–loop–helix of the
gating brake in the I–II cytoplasmic linker
Cav3 channels lack the canonical C-terminal IQ motif
(FILV)QXXX(RK)GXXX(RK)XX(FILVWY) of Cav1 L-type
Ca2 channels or (FILV)QXXX(RK)XXXXXXXX Nav1 sodium
channels for CaM association (51). One of the criteria for a
potential CaM-binding motif is its omnipresence from micro-
bial eukaryotes to humans such as the IQmotif within different
Cav1 and Nav channels (9). This criterion was satisfied with the
predicted CaM association in the second helix of the helix–
loop–helix motif forming the Cav3 gating brake in the I–II
linker of almost all known Cav3 channels. All 26-mer gating
brake sequences are similar (e.g. 71–76% between pond snail
and human Cav3 isoforms) but are also completely lacking the
string of identical and canonical amino acids conserved in
the IQ motif in different Cav1 and Nav channels. Interestingly,
the most basal of multicellular organisms, the placozoan spe-
ciesT. adherens, possess a Cav3 T-type channel (40) but lack an
identifiable gating brake motif (only 10% similarity to pond
snail and human Cav3 isoforms). In its place, the Trichoplax
channel sequence is similar to the IQ motifs of L-type calcium
channels (48% to the human Cav1.2). It is highly suggestive that
the earliest eukaryotic Cav3 T-type channels had a CaM-bind-
ing IQmotif shared with other Cav and Nav channels, before its
divergence and establishment of its unique identity in Cav3
T-type channels, as the gating brake.
Conformational changes in both Ca2–CaM and CaMB
peptides are observed upon their high nanomolar affinity
association
Nanomolar and specific CaM binding to Cav3 CaMB pep-
tides are corroborated in the ability of Ca2–CaM to increas-
ingly associate with Cav3 CaMB peptides corresponding to
increasing concentrations of the Cav3 CaMB peptides illus-
trated by gel-mobility-shift assays. Cav3 CaMB peptides appear
to undergo dramatic conformational changes (i.e. increasing
-felicity) on association with Ca2–CaM illustrated by circu-
lar dichroism. Although ellipticity changes in the circular
dichroism likely involve the induction of -helices in the pep-
tide upon bindingCaM, some of the changesmay be induced by
tertiary structural changes in the proteins themselves (43). The
association of the Cav3 CaMB peptides with CaM generates
dramatic conformational changes in Ca2–CaM, illustrated by
amide chemical shifts of CaM’s amino acids in 1H-15N HSQC
NMR spectra spanning both N- and C-terminal lobes of CaM.
Thermodynamic properties measured within the isothermal
cell of the Ca2–CaM complexing with Cav3 CaMB peptides
illustrate that Ca2–CaMandCav3CaMBpeptides associate in
a 1:1 stoichiometry (N value) at a high nanomolar association
constant (Ka).
Figure9.Overexpressionofapo-CaM/CaM1234 (Ca
2-bindingdeficientCaM) causesahyperpolarizing shift involtage sensitivities and faster channel
kinetics inCav3.2 channels only in thepresenceof an intact gatingbrake inCav3.2.A and B,Cav3.2 channelswith andwithout co-expressedCaM1234were
measured for their current-voltage relationships and  for mono-exponential fits of the kinetics of activation (A) and inactivation (B). Representative current
traces are shown. Results are presented as mean	 S.E., and n
 the number of cells. Statistical analyses were first performed with the Student’s t test or with
one-wayANOVA combinedwith a Tukey post-test formultiple comparisons (*, p 0.05; **, p 0.01; ***, p 0.001).C, scatter plot (left) withmean	 S.E. (right)
values illustrate the 50% activation and inactivation values taken from Boltzmann fits of activation and steady-state inactivation curves of Cav3.2 channels
alone (), and Cav3.2 channels with co-expressed apo-calmodulin (CaM1234) or calmodulin (CaM). Voltage responses to co-expressed apo-calmodulin
(CaM1234) are also illustrated forCav3.2deletionmutants spanning sequences429–539or 453–491, lacking the111or 39aminoacids, respectively, flanking the
gating brake in the I–II linker. The region of deletionmutants spanning the gating brake of Cav3.2 channels are illustrated in Fig. 2B. The statistical significance
of CaM1234 overexpression comparedwith wild-type conditions was p
 0.0028 (***) and p
 0.0308 (*) for V50% activation and V50% inactivation, respectively,
usingaKruskal-Wallis test followedbyaDunn’smultiple comparisons test. Theeffect ofCaM1234overexpressioncomparedwithwild-typeconditions forCav3.2
deletion mutants (D429–539 or D453–491) were non-significant using a Mann-Whitney test.
Calmodulin at the T-type channel gating brake
J. Biol. Chem. (2017) 292(49) 20010–20031 20021
 at U
CL Library Services on January 26, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Highest affinity association of Ca2–CaMCaMB peptides
requires both lobes of CaM and their Ca2-binding sites
Further evidence of the specificity of the Cav3 CaMB pep-
tides to Ca2–CaM is in the requirement of intact Ca2–CaM
for high nanomolar affinity binding. We show that the N-lobes
and C-lobes of CaM alone will associate with Cav3 CaMB pep-
tides, but at a lower measurable affinity compared with both
CaM lobes. The high-affinity of CaM for Cav3 CaMB peptides
requires intact Ca2-binding sites for CaM, as evidenced by the
greatly weakened affinity of CaM in the CaM1234 configuration
for the Cav3 CaMB peptides.
Different sequences for CaMB peptides from sample
invertebrate LCav3 andmammalian Cav3 channels possess a
high nanomolar affinity and similar binding properties in
complexingwith Ca2–CaM
Differing sequences of CaMB peptides for snail LCav3 and
the three human Cav3 gene isoforms are 71–76% similar to one
another and possess similar binding properties with Ca2–
CaM. Snail LCav3 and the different humanCav3 isoforms of the
CaMB peptides associate with a nanomolar affinity and in a 1:1
stoichiometry with Ca2–CaM. All CaMB peptides assume a
greater -helicity upon association of Ca2–CaM, except the
alanine-richCav3.1 isoform, and both snail LCav3 andmamma-
lian Cav3.2 CaMB peptides generate similar and large confor-
mational changes to both N- and C-lobes of CaM as measured
by the amide chemical shifts of CaM’s amino acids in 1H-15N
HSQC NMR spectra. Both snail LCav3 and mammalian Cav3.2
CaMBpeptides also associatewithCa2–CaMat amuchweak-
ened affinity when Ca2-binding sites are mutated in CaM.
Differing sequences of CaMB peptides differ in their relative
affinities for Ca2–CaM
The sequence differences between the Cav3 CaMB peptides
contributed to significant differences in binding affinities,
which varied from rank order of highest to lowest binding affin-
ities of LCav3  Cav3.1  Cav3.2  Cav3.3 of 12, 43, 187, and
383 nM, respectively. The rank order of binding affinities mea-
sured by the thermodynamic changes resulting from the 1:1
complexing of Cav3 CaMB peptides and Ca2–CaMmeasured
in the isothermal cell is also the same observed rank order of the
fold concentration of Cav3 CaMB peptides required for satura-
tion of Ca2–CaM with Cav3 CaMB peptides for a complete
gel-mobility shift.
Nanomolar affinities of Cav3 CaMB peptides are
approximately equivalent to themeasured high affinities of
the IQmotif of Cav1.2 and Cav2.1 channels and greater than
the affinity of Ca2–CaM for Nav1.5 channels
Our measured binding affinities of Cav3 CaMB peptides for
N- and C-lobes of Ca2–CaM (in nM) of 31	 1.9 and 690	 42,
respectively, is in the relative range of nanomolar affinities for
CaM as the C-terminal IQ domain of Cav1.2 of 57.6	 35.5 and
2.63 	 0.07 (52) and the C-terminal IQ domain of Cav2.1 of
51 	 20 and 4.32 	 0.39 (53). The higher nanomolar binding
affinity of the Cav3.2 channel CaMB peptides for N- and
C-lobes of Ca2–CaM is greater than NSCaTE, a secondary
CaM-binding site of Cav1.2 channels (in nM): 650 	 60 and
1330 	 300 (16), respectively. Cav3.2 channel CaMB peptides
are also much higher affinity than the micromolar binding
affinity range for the N- and C-lobes of Ca2–CaM of Nav1.5
sodium channel fragments (in nM), such as its C-terminal IQ
domain of 2170	 400 and 6130	 900 (6) and the III–IV linker
of 19,270	 940 and500,000, respectively (54).
Phenotype after dialysis of Cav3 CaMB peptides corresponds
to immobilizing the gating brake in the I–II linker
Our biochemical studies reflect that Ca2–CaM associates
with helix-2 of the gating brake in both invertebrate and all
mammalian isoforms of Cav3 channels, in a high nanomolar
affinity with binding characteristics that is reminiscent of the
canonical binding of Ca2-CaM to the proximal C-terminal IQ
motif of Cav1 and Cav2 channels. We then tracked the conse-
quences of introducing the high-affinity CaMB peptide in
expressed Cav3.2 channels in real time, by comparing the bio-
physical changes to the Cav3.2 channels from the start of a
stabilized patch-clamp recording (0 min) and after complete
dialysis of 5 M CaMB peptides from our patch pipette (15–20
min). Biochemically, we observed that equivalent mutated
CaMBpeptide did not associatewithCa2–CaM, so it served as
a control to compare the effects of the CaMB peptide. We
observed 8- and 16-mV hyperpolarization shifts in activa-
tion and inactivation curves, respectively, as a result of CaMB
peptide dialysis. Faster channel kinetics were also observed,
which are a likely a consequence of the hyperpolarizing shift,
because corresponding kinetic changes are usually associated
with shifts in voltage sensitivities within Cav3 T-type channels
(37). The target for the CaMB peptide effect was the gating
brake, as we observed no additional hyperpolarizing shift in
voltage sensitivities after CaMBpeptide dialysis in Cav3.2 chan-
nel mutants lacking the gating brake. We carried out the com-
plete set of electrophysiology experiments using mammalian
Cav3.2 because of the availability of gating brake mutants. We
will carry out future analyses to confirm the hyperpolarizing
shifts in voltage sensitivities in response to CaMB peptide dial-
yses are shared among other Cav3 T-type channels, including
invertebrate LCav3, all of which have a common nanomolar
affinity for CaM binding to the gating brake.
Overexpression of Ca2-binding deficient CaM (i.e. CaM1234)
reveals that CaMB peptides likely compete for CaM binding at
the gating brake in the I–II linker of Cav3 channels
Involvement of CaM regulation of ion channels has been
supported by introducing a Ca2-insensitive mutant form of
CaM (CaM1234), which possess point mutations within both
pairs of EF hands in the N- and C-lobes of CaM to eliminate
Ca2 binding (44). It is believed that CaM pre-associates onto
its target in the apo-CaM form (lacking Ca2 occupied in its EF
hands) (55–57). CaMBpeptides have ameasurable affinity with
CaM1234, albeit at levels that are 12- and 349-fold lower
compared with wild-type CaM, for Cav3.1 and LCav3 CaMB
peptides. Apo-CaM bound to its channel target is considered a
necessary antecedent to the subsequent regulation of CaM by
Ca2. Overexpression of the mutant apo-CaM, which is inca-
pable of binding Ca2, is thus considered a competitive inhib-
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itor to silence the effects of Ca2–CaM. For example, the dom-
inant-negative effects of CaM1234 overexpression have been
used to illustrate the importance of Ca2–CaM in the gating of
small-conductance Ca2-activated K channels (44), and the
necessity of Ca2–CaM in the Ca2-dependent inactivation of
Cav1 L-type channels (58, 59) as well as the calcium-dependent
facilitation of Cav2 channels (60). We observe that CaM1234
causes a modest (6.7 and 7.2 mV) hyperpolarizing shift in acti-
vation and inactivation curves of Cav3.2 channels, respectively,
compared with wild-type CaM overexpression. The likely tar-
get for the CaM1234 effect is the gating brake, as we observed no
additional CaM1234 causing hyperpolarizing shifts on Cav3.2
channels lacking the gating brake.
Combined biochemistry and electrophysiology data highly
suggest that Ca2–CaM is a high-affinity resident sensor at
the gating brake of Cav3 channels
To summarize our data, we illustrate that CaM1234, consid-
ered as a substitute for apo-CaM (CaM in the absence of cal-
cium), associateswith helix-2 of the gating brake at a lowmicro-
molar affinity. Upon binding Ca2, CaMB peptides and CaM
both undergo dramatic conformational changes, leading to
CaM’s tighter association at the gating brake at a higher nano-
molar affinity. Our data suggest that Ca2–CaM is behaving as
a similar high-affinity and resident sensor at the gating brake in
the I–II linker of Cav3 T-type channels, in both sample inver-
tebrate and the three human gene isoforms, in a universal man-
ner similar to the calcium–CaM regulation on the IQ motif
containing C-terminal tails of Cav1 and Cav2 calcium channels
(1–5) and Nav1 sodium channels (6). Introducing CaMB pep-
tides or CaM1234 competitively inhibits Ca2–CaM at the gat-
ing brake of Cav3.2 channels, generating a runaway gating phe-
notype, with hyperpolarized shifts in voltage sensitivities that
are even greater than observed after deletion of the brake from
Cav3 channels. Because the introduced CaMB peptides or
CaM1234 have no effect on Cav3.2 channels with a missing gat-
ing brake, it suggests that the primary target for Ca2–CaM is
the gating brake of Cav3 channels.We did not observe the com-
plexing of full-length Cav3.1 and Cav3.2 channels with CaM
in vitro in the absence of calcium ions, but we suspect that it
may relate to the structural requirements for calcium ions in
recapitulating the native behavior of full-sized, Cav3 channels
in vitro, the sensitivities of our assays, and the technical chal-
lenges in working with whole ion channel proteins of such large
sizes (259 kDa) in vitro.
Cav3.3 exhibits a similar calcium-dependent CaM regulation
as other calcium and sodium channels
Consistent with our findings here, Lee et al. (50) report a
hyperpolarizing shift in activation and inactivation curves of
Cav3.3 channels and faster inactivation kinetics, under condi-
tions where intracellular free calcium is at a higher (1 M) but
not lower (27 nM) calculated concentration. Lee et al. (50) also
observe a faster inactivation kinetics in Cav3.3 channels associ-
atedwith external calcium comparedwith barium as the charge
carrier. The much faster inactivating mammalian T-type chan-
nels, Cav3.1 and Cav3.2, do not appear to exhibit the same
calcium-dependent change in biophysical properties as Cav3.3
channels but possess a more pronounced voltage-dependent
inactivation (61). Lee et al. (50) illustrate that rat Cav3.3 chan-
nels possess a unique C-terminal sequence that associates with
Ca2–CaM, conferring the unique CaM regulation observed
for Cav3.3 channels.
Observed variability of the Ca2-dependent regulationwithin
Cav3 channels is consistent with the variability in Ca
2–CaM
bindingwithin the Cav1 L-type channels
A suggested hypothesis is that all Cav3 channels possess a
central, high-affinity Ca2–CaM binding at the gating brake in
the I–II linker, with additionalmodulatory, intracellular Ca2–
CaM-binding sites elsewhere, which can confer novel attri-
butes, such as the Ca2–CaM regulation at the C terminus for
Cav3.3 channels (50). A highly customizable form of Ca2–
CaM regulation is observed within the “IQ motif centric”
calcium (Cav1 and Cav2) and sodium (Nav1) channels. The pre-
occupancy of CaM at the primary IQ motif in the absence of
Ca2 ions is one form of regulation. The specialized Cav1.4
homolog localized in vertebrate photoreceptors possesses a
highly conserved IQ motif but exhibits almost no calcium-de-
pendent inactivation compared with closely-related Cav1.2
channels. Cav1.4 possess a distal C-terminal auto-inhibitory
domain, which effectively competes for apo-CaM for binding,
thus preventing Ca2–CaM regulation at Cav1.4’s conserved
proximal C-terminal IQ motif (62). Cav1.3 possess a similar
auto-inhibitory domain in the distal C terminus generated
through alternative splicing, which competes with apo-CaM
(63, 64).
Another source of variability is in the semi-autonomy and
cooperativity among CaM’s pairs of Ca2-binding EF hands in
the N- and C-lobes, each of which is capable of conferring
unique attributes. For example, the Ca2–CaM-binding site
NSCaTE shared within the N terminus of invertebrate Cav1
channels (9) and mammalian Cav1.2 and Cav1.3 channels (16,
17) interacts specifically with CaM’s N-lobes, conferring a
capacity for more global Ca2-sensing and buffer-resistant
calcium-dependent inactivation in classical L-type channels.
The C-lobe of CaM is occupied with the IQ motif, imparting a
local, more rapid, and spatially restricted calcium-sensing of
Ca2 ions (16, 17).
Observed variability of the Ca2-dependent regulationwithin
Cav3 channels is consistent with the variability in Ca
2–CaM
bindingwithin the Cav2 synaptic Ca
2 channels and Na
channels
The bipartite nature of CaM’s N- and C-lobes is also evident
in the synaptic Cav2 channel family, where Ca2 regulation
manifests as a rapid, calcium-dependent facilitation of the cal-
cium current triggered at CaM’s C-lobe and a slower-develop-
ing calcium-dependent inactivation imparted by CaM’s N-lobe
(60, 65).
One confounding issue is a potential interplay between cal-
cium- and voltage-dependent properties, such as the conse-
quences of a Ca2–CaM-binding site identified in the III–IV
linker of Nav1.5 sodium channels, which is also the region
responsible for the fast voltage-dependent inactivation within
sodium channels (6, 54, 66). The contributions of both calcium-
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and voltage-dependent properties can obscure the typical
U-shaped calcium-dependent inactivation (39).
Technical challenges inmeasuring the Ca2 occupancy of
CaM in vivo
Observations in vitro often do not correlate to those gathered
within different cell types too, where different factors influence
CaM’s effects within the cellular environment. For example,
when CaM has many high-affinity targets within a cell, it has
been reported that CaM availability is likely to be limiting in
many cell types (67, 68). In such cases, CaM regulation may be
unavailable because individual CaMs may be preoccupied at
different high-affinity cellular targets. There is also likely com-
petition among differing calcium-sensing proteins. A good
example is calcium-binding protein expressed in the vertebrate
nervous system, whose expression can antagonize CaM-depen-
dent regulation of Cav1 L-type channels (69).
The last confounding issue with studies involving CaM is in
the technical challenge in modeling calcium availability for
CaM regulation. It is challenging to precisely measure native
calcium-buffering conditions because they are variable within a
particular cell or among different cell types. Ion channel studies
usually involve intracellular dialysis in the whole-cell patch-
clamp configuration of intracellular calcium chelators (e.g.
EGTA and BAPTA), which impose artificial calcium-buffering
conditions, whose calcium affinity and on-off rates are not
known in comparison with the native buffering conditions
in vivo.
Universal “calmodulation” among sodium and Ca2 channels
also involves Cav3 channels
Cav3 channels are the least well studied of the calcium or
sodium channels, which means that Cav3 channels are inter-
preted through the lens of what is understood for other calcium
and sodium channels (37). A universal IQ centric calmodula-
tion of sodium and calcium channels has more variations than
commonality by the many interactions that fine-tune the
Ca2–CaM regulation outside of the primary C-terminal IQ
motif. So it should not be surprising that a functional Ca2–
CaM regulation is only evident within one of three mammalian
Cav3 channels in preliminary analyses, and lacking evidence so
far within Cav3.1 and Cav3.2 channels (50). Despite possessing
proximal C-terminal Ca2–CaM binding in the IQ motif and
the III–IV linker, cardiac muscle Nav1.5 channels possess no
obvious Ca2–CaM regulation, whereas skeletalmuscleNav1.4
has a robust calcium-dependent inactivation (2, 70, 71). A
deeper molecular analysis uncovered, for example, a Ca2–
CaM regulation of classical L-type channels within Cav1.4
channels, after deletion of its C-terminal auto-inhibitory
domain (62).
Potential implications for Cav3 channels possessing
Ca2–CaM regulation at the gating brake
Cav3 channels are equally distant structurally to both cal-
cium and sodium channels (37), and it should come as no sur-
prise that its Ca2–CaM regulation is also strikingly different,
where the equivalence to the C-terminally positioned IQ motif
is transposed onto a different cytoplasmic region. The gating
brake is a unique element within all Cav3 T-type channels,
which tunes the unique low voltage sensitivity of this channel
class (72). The gating brake is a position that overlaps with the
Alpha1 Interaction Site of Cav1 and Cav2 calcium channels
where accessory Cav subunits regulate their expression levels
and biophysical properties (25). Cav3 T-type channels lack
equivalency of the high-nanomolar affinity Cav subunit-bind-
ing site within Cav1 and Cav2 calcium channels (73). It is pos-
sible to confer Cav subunit regulation onto Cav3 T-type chan-
nels after transplanting the I–II linker fromCav2 channels (45).
But in their native state, Cav3 T-type channels possess remark-
ably similar properties as their in vivo counterparts without
requirement of co-expressed accessory subunits in inverte-
brates (74) and mammals (45, 75). Cav subunits will boost the
level of expression of invertebrate (76) and mammalian (75)
Cav3 T-type channels, but this is considered to be the result of
indirect and generalized consequences of overexpressing a
multifunctional, scaffolding, and regulatory protein, such as the
Cav subunit in vitro (77).
With a lack of equivalent accessory subunit interactions
within Cav3 channels, opportunities are created for a Ca2–
CaM regulation within the gating brake of the I–II linker. The
gating brake is placed in the I–II loop, just downstream of a stiff
-helical linker extending from the segment 6 of domain II,
which contributes to pore opening (72). Affixing Ca2–CaM to
the I–II loop may have structural implications because the I–II
loop is immobilized at both ends comparedwith theC-terminal
tails containing the IQ motif of sodium and calcium channels,
which is linked only a single end. Amore proximate location of
the gating brake to the intracellular pore mouth may also have
implications, contributing to a unique Ca2–CaM regulation
within Cav3 channels.
Potential importance of Ca2–CaM regulation of Cav3
channels for human physiology and disease
The unique high-affinity binding and regulation of CaM at
the gating brake ofCav3T-type channels has dramatic potential
consequences, because of the gating brake’s role as a primary
regulator of the voltage sensitivity of Cav3 T-type channels.
Cav3 T-type channels are unique among sodium and calcium
channels by the low voltage range of activation that is close to
typical restingmembrane potentials. CaM at the gating brake is
perfectly positioned in Cav3 channels for fine-tuning the chan-
nels’ responsiveness to voltage, providing ameans to govern the
capacity of Cav3 T-type channels to facilitate pacemaker
rhythms where T-type channels have established roles, such as
the thalamo-cortical circuits of the brain (where Cav3 T-type
channel expression is highest) and the conducting system in the
heart (49). Humanmutations in the gating brake are associated
with arrhythmic vulnerabilities such as epilepsy (27, 28) or
autism spectrum disorder (78), and it is the platform where
Ca2 andCaMcanmodulate the low-voltage gating behavior in
T-type channels, in amanner that is unique from the regulation
of CaM universally at the IQ motif in the C-terminal tails of
Cav1 and Cav2 calcium channels (1–5) and Nav1 sodium chan-
nels (6).
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Outside of Ca2–CaM regulation, Cav3 channels are very
different from other calcium and sodium channels
Cav3 channels uniquely different Ca2–CaM regulation goes
alongside itsmany observed differences fromother sodium and
calcium channels. This includes their ion selectivity, which can
range from mostly calcium-conducting (Cav3.1 and Cav3.2),
equally sodium- and calcium-conducting (Cav3.3) and as
sodium-conducting as Nav1 sodium channels (protostome
invertebrate Cav3 channel isoforms).
We have shown that most non-vertebrate Cav3 T-type chan-
nels have alternative splicing of the L5 extracellular turret in
domain II, which converts the mostly calcium-conducting
T-type channel into a highly sodium-conducting isoform,
whose expression in the invertebrate heart serves as the pri-
mary sodium current (74). The plasticity of invertebrate Cav3
channels in assuming calcium- or sodium-conducting pore
configurations is to expand their niche in the absence of Nav1
channel genes expressed outside of the nervous systems of
many invertebrates, and in themany species of non-vertebrates
completely lacking any Nav1 channel in their genomes (nema-
todes, echinoderms, hemichordates, and parasitic flatworms)
(74). It is an interesting question to address how Ca2–CaM
regulation varies when Na is the primary conducting ion
rather than Ca2 through differing invertebrate Cav3 channel
isoforms.
Potential role for calcium sensing at the gating brake is in
influencing calcium ion selectivity within Cav3 channels
We have shown that the Cav3 channels are endowed with
2-fold increase in the number of cysteines in L5 and L6 extra-
cellular turrets, contributing to uniquely folded extracellular
scaffolds (79). In particular, alternative turrets with unique cys-
teine configurations in both DII L5 and DIV L6 regulate the
degree of sodium and calcium conductances through inverte-
brate Cav3 channels.4 Deletion of these unique L5 cysteines in
domain II, alters drug affinity, divalent cation block with Ni2
and Zn2, and also increasing the apparent pore size, allowing
for the accommodation of a simultaneous flowof bothmonova-
lent and divalent cations.5 The simultaneous flow of differing
divalent andmonovalent ionsmay only be possible within Cav3
T-type channels, given its likely wider, more accommodating
EEDD selectivity filter compared with other Cav1 and Cav2 cal-
cium channels with an EEEE selectivity filter (49). One of the
possible implications of a high-affinity calcium sensor, such as
CaM near the internal mouth of the pore, is in its potential in
influencing calcium ion conductance.We observe an apparent
simultaneous flow of monovalent and divalent ions through
Cav3 channels containing mutated cysteines in the domain
II, L5 extracellular loop, which is only possible if the divalent
cation alongside the monovalent (e.g. Na) is either Sr2 or
Ba2 but not Ca2.5 A high-affinity calcium sensor, like CaM
at the pore mouth, may contribute to the explanation for the
observations that Ca2 appears as the dominant and pre-
ferred divalent ion carrier through the Cav3 channel pore,
even when the channel is highly sodium-conducting.5
Experimental procedures
Expression of Cav3 constructs
The cDNAs encoding for Cav3.2 were previously character-
ized (61) as well as hemagglutinin (HA) epitope-tagged Cav3
subunits expressed using pcDNA 3.1 vector (23, 75). We illus-
trate how to maintain HEK-293T cell lines and introduce cal-
cium channel expressible plasmids for transient transfection,
expression, andwhole-cell patch-clamp recording in an on-line
video (JoVE) format (82). HEK-293T cells were cultured as
described previously (23, 75). For optimal transfection, cells
were plated at 50–70% confluence. Cells were transfected using
the JetPEI transfection reagent (QBiogene) according to the
manufacturer’s protocol. In all conditions, corresponding
empty plasmids were used to adjust the quantity of the trans-
fected material (1 g of each plasmid/35-mm dish). Gating
brake deletionmutants for Cav3.2, D429–539, and D453–491 were
used previously (23).
Expression of CaM, CaMmutant, and CaM knockdown
constructs
Wehave used humanCaMand associatedCaMmutants that
we have described before (9), CaM(1–44) and partial CaMs:
N-CaM(1–74), C-CaM(75–148), and CaMs that simulate CaM
binding in the absence of calcium, by substitution of glutamate
residues in the two calcium-binding sites in theN-terminal lobe
(CaM12) or C-terminal lobe (CaM34), or mutation of all four
calcium-binding sites (CaM1234) of CaM. CaM–GFP used for
Western blotting is a construct consisting of GFP fused to the C
terminus of CaM expressed in pcDNA3.1 (Cell Signaling Tech-
nology) (83). EGFP expression vector was obtained by subclon-
ing EGFP from pEGFP-C1 (BD Biosciences) into the multiple
cloning site of pcDNA3.1. The CaM1234 overexpression con-
struct contained bicistronic marker mRFP (to generate a red
color) (46) to distinguish from the channel expression with
bicistronic EGFP (to generate a green color). The CaM1234
overexpression construct also containing CaM shRNA knock-
down includes two short hairpin sequences described above to
knock down CaM (Calm1,2,3 genes) (46–48). The shRNA
knockdown sequences is reported to be 70% complete in dis-
abling of native CaM expression (46–48), but this knockdown
was insufficient for our purposes, as we observed no significant
physiological consequence after transfection of the shRNA
CaM knockdown alone.
Synthetic peptide experiments
We purified bacterially expressed His-tagged CaM (CaM)
and measured in vitro association with 26-mer synthetic pep-
tides (BioBasic) spanning the gating brake of human Cav3.x,
Cav3.2GBmut, and snail LCav3 in gel-shift mobility assays, dif-
ferential circular dichroism, and isothermal titration calorime-
try.We followed protocols that we have described previously in
an analysis of CaM binding with snail or human L-type calcium
channel peptides in the presence of 0.1 or 0.5 mM CaCl2-con-
taining solution (9).
4 R. F. Stephens,W. Guan, O.Mourad, A. Mehta, and J. D. Spafford,manuscript
in revision.
5 W. Guan, R. F. Stephens, and J. D. Spafford, manuscript in revision.
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CaMprotein expression for biochemistry experiments
Rat CaM was purified using phenyl-Sepharose 6 Fast-Flow
(High Sub) (GEHealthcare), packed to10ml volume, by grav-
ity flow at 4 °C. Codon-optimized CaMwas cloned in pET9d, a
T7 Escherichia coli expression vector. CaM was transformed
into BL21 DE3 E. coli and grown at 37 °C and 200 rpm toOD of
0.4–0.6 (for Luria Broth, LB) or 0.5–0.9 (for SuperBroth, SB), at
which point samples were induced by 1 mM added isopropyl
-D-1-thiogalactopyranoside and grown for another 4 (for SB)
to 6 (for LB) h. Robust expression of soluble CaM was con-
firmed by SDS-PAGE. Cells were collected by centrifugation at
4000 g, then lysed in high-salt buffer (0.1 M Tris-Cl, pH 7.5,
0.5 M NaCl, 0.5 M ammonium sulfate, 1 mM DTT) using an
Avestin Emulsiflex homogenizer at 15,000–20,000 p.s.i. with
jacketed water cooling, through which the cells were passed
3 on average. The cell lysate was clarified by centrifugation
at 20,000 rpm in an SS-34 rotor (50,000  g) at 4 °C for 30
min. To the cleared lysate, CaCl2 was added to a final concen-
tration of 10 mM. The lysate was then applied to the gravity
phenyl-Sepharose column equilibrated with the same high salt
buffer (and 1 mM CaCl2). The column was washed with high-
salt buffer. CaM was then eluted using 10 mM Tris-Cl and
EDTA solution, pH7.5. The highest fractionswere pooled, con-
centrated, and applied to the preparation grade Superdex 75
16/60 column (GEHealthcare) on anAKTAFPLC system.Typ-
ical injection volume was 1 ml, and the gel filtration buffer (50
mM Tris-Cl, pH 7.5, 150 mMNaCl, 1 mM CaCl2) was set to flow
at 1 ml/min. Wild-type CaM reproducibly elutes at68 ml on
this column. Elution peak width is dependent on the amount of
CaMpresent; routinely up to 10 1-ml fractionswere obtained of
concentrations 200–400 M; these were pooled and concen-
trated using the spin concentrators from Sartorius or Amicon
(10,000molecular weight cutoff). Extinction coefficient of 3006
M1 cm1 atA276 was used (66), and the final protein stock was
aliquoted to 500 l and stored at80 °C.
Purification of Ca2-deficient CaM proteins
The interaction of CaM with hydrophobic interaction chro-
matographymedia depends on its exposure of the hydrophobic
residues upon Ca2 binding. The phenyl-Sepharose method is
not nearly as efficient for the purification of CaM12, CaM34, or
CaM1234. So for Ca2-deficient CaM proteins, we used a com-
bination of ion-exchange chromatography and subsequent gel
filtration for purification. A Q-Sepharose (quaternary ammo-
nium) 6-ml column (GEHealthcare) was used for ion exchange.
Lysis and low-salt buffer consisted of 5mMBisTris, pH 6.0, with
no Ca2 or EDTA. Lysis buffer also had DTT added to 1 mM
final concentration to maintain CaM’s methionines in the
reduced state. CaM12, CaM34, and CaM1234 (in pET28a vector)
were expressed and harvested in same manner as wild-type
CaM. Cells were lysed using the Avestin Emulsiflex homoge-
nizer (15,000 p.s.i.), clarified by centrifugation at 50,000
g, and applied to the column (ion exchange was done using the
AKTA FPLC system, same as for gel-filtration chromatogra-
phy). The column was then briefly washed with low-salt buffer
(5–10 column volumes), and a shallow salt gradient was applied
(100 mM NaCl over 10 column volumes). Subsequently, the
column proteins were eluted with a steep gradient (1.6 M NaCl
over 2 column volumes, held for 2more column volumes), after
which the columnwas re-equilibrated or cleaned. The resulting
fractions were analyzed by SDS-PAGE and read for absorbance
levels at 278 nm. Best candidates were pooled and concentrated
using YM-10 spin columns (Millipore) and further purified by
gel-filtration chromatography. Purity of the CaM proteins was
confirmed by SDS-PAGE and ESI-MS (electrospray ionization-
mass spectrometry), and their concentrations were determined
using the modified Bradford assay (84) (with wild-type CaM as
the standard), aliquoted, and stored in gel filtration buffer at
80 °C.
Bioinformatic analyses of peptide sequences
Protein parameters (pI and molecular weight) were deter-
mined using the prediction tool in ExPaSy (http://web.expasy.
org/protparam/),6 and the aggregation propensity was deter-
mined using the on-line software at Centre for Genomic Regu-
lation (http://tango.crg.es/).6 All phylogenetic alignments were
done using variations of the BLAST tool on the GenBankTM
web site. The CaM-binding site prediction database (http://
calcium.uhnres.utoronto.ca/ctdb/contacts/index.htm)6 was
used to search for other possible “hits” in the channel ORFs
(39) and to design optimal peptide sequences for synthesis.
Native Trp fluorescence
Steady-state measurements were obtained using a Photon
Technologies International Quantamaster Fluorimeter (Lon-
don, Ontario, Canada) in a 50-l 1-mm fluorescence cuvette
(Hellma) at room temperature. The same buffer was used as for
gel filtration and ITC experiments (50 mM Tris-Cl, pH 7.5, 150
mM NaCl) with either 1 mM CaCl2 or 10 mM EDTA; buffer was
used as a baseline for subtraction. To the cuvette containing the
starting peptide solution (25 M), increasing amounts of CaM
were added (in increments corresponding to 2.5 M). Step-
wise mission scans from 300 to 400 nm using a 280-nm excita-
tion wavelength and 1-nm slit width (averaging over 1s each)
were performed.
Dansyl-CaM fluorescence
Dansyl (5-(dimethylamino) naphthalene-1-sulfonyl chlo-
ride) is an amine-reactive fluorescent dye. Dansyl-CaM was
prepared as described previously (85). CaM (1 mg/ml) was
transferred into 10mMNaHCO3, 1mM EDTA, pH 10.0, at 4 °C.
30 l of 6 mM dansyl-chloride (1.5 mol/mol of CaM) in DMSO
was added to 2 ml of CaM, with stirring. After incubation for
12 h at 4 °C, the mixture was first dialyzed against 500 volumes
of 150 mMNaCl, 1 mM EDTA, 20 mM Tris-HCl, pH 7.5, at 4 °C,
and then dialyzed against 500 volumes of water. Labeling yields
were determined from absorbance spectra using the 320 of
3,400 M1 cm1 and were compared with protein concentra-
tions determined using the Bradford method with wild-type
CaM used as the protein standard (86) ESI-MS was used to
confirm successful dansyl-labeling of CaM protein. The con-
centration of dansyl-CaM in all experiments was 2 M. Steady-
6 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
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state fluorescence was performed in a similar manner as the
Trp experiments, except that a newer Fluorolog 3-22 (Horiba
Scientific, Ltd.) fluorimeter was used, and the buffer used was
10 mM HEPES, pH 7.0, with supplemented 0.1 mM CaCl2.
Differential circular dichroism
CD measurements were performed using a Jasco-715 spec-
tropolarimeter (Jasco Instruments, Easton, MD), using the fol-
lowing parameters: 250–190-nm range, 50 nm/min speed, with
1-s response time, 1-nm bandwidth, and 100-millidegree sen-
sitivity at room temperature. 16–25 accumulations were gath-
ered depending on signal quality. Recordings were made in a
1-mm cuvette, in 10 mM sodium phosphate buffer with 0.1 mM
added CaCl2, and used as baseline, which was subtracted from
each recording. For CaM and CaMB peptide spectra, the same
solution of 10 M CaM was scanned before stock (1 mM) pep-
tide was added in incremental amounts before being scanned
again. The resulting spectra were subtracted (e.g. CaM and
CaMB peptide-CaM alone) to extract the spectrum corre-
sponding to the change associated with adding the peptide.
Every recordingwas an average of at least 16 accumulations and
subsequently corrected for protein concentration (converted to
units of mean residue ellipticity). These were smoothed and
exported into ASCII format for analysis with Excel and either
SOMCD or Dichroweb K2d algorithm (http://dichroweb.cryst.
bbk.ac.uk)6 (92, 93). TFE recordingswere performed using pure
2,2,2-trifluoroethanol (Sigma) at 10, 25, and 50% after thorough
pre-mixing and incubation with peptides in the phosphate
buffer, baseline-corrected against the sameTFE/buffer solution
without peptide. LCav3 and Cav3.2 CaMB peptides were con-
tained in PBS buffer (10mM sodiumphosphate, pH 7.3, 137mM
NaCl, 2 mM KH2PO4, and 2.7 mM KCl). Cav3.1, Cav3.3, CaMB
peptides were characterized in low ionic strength buffers due to
severe aggregation issues in PBS. Low ionic strength buffer for
Cav3.1 and Cav3.3 CaMB peptides was composed of 10 mM
HEPES, pH 7. A 0.1-cm quartz cuvette (Hellma) was used for
CDmeasurements. CaM-binding experiments were performed
by adding increments of stock (1 mM) CaMB peptide to the
same cuvette containing 10MCaM(300l). Subsequent scans
would then have the CaM-only trace subtracted and corrected
for total peptide concentration, smoothed, and converted to
mean residue ellipticity units.
Gelmobility-shift assays
Gel assays were run in native conditions with 4 M urea, con-
taining 15% acrylamide separating and 4% stacking gels. Run-
ning buffer contained 192 mM glycine, 50 mM Tris-Cl, 0.1 mM
CaCl2, pH 8.3. Separating gel buffer (2) contained 0.7 M
Tris-Cl and 1mMCaCl2, pH8.8. Stacking buffer (2) contained
0.5 M Tris-Cl and 1mMCaCl2, pH 6.7. Peptides were incubated
with CaM for1 h at 4 °C in gel filtration buffer (150mMNaCl,
50 mM Tris-Cl, pH 7.5, 1 mM CaCl2) prior to loading. 50% glyc-
erol was used in the gel filtration buffer, and0.1% bromphenol
blue (as tracker dye) was used at 1:2 sample volume just prior to
loading for each sample. Gels were run at 100 V in 4 °C jacketed/
ice-bath conditions for 6–8 h as needed. All gel-mobility-shift
assays were confirmed in three replicate experiments.
Isothermal titration calorimetry
Heat gain or heat requirements in the sample cell (for exo-
thermic binding or endothermic binding, respectively) corre-
spond to the direction of the injection peaks measured in the
isothermal titration calorimeter (MicroCal iTC200, Malvern
Instruments, UK). The peaks were integrated and plotted as a
sigmoidal plot of cal (concentration of the ligand in the cell)
versus mol of injectant (protein concentration in the syringe).
Origin 2017 software (OriginLab) was used to fit the resulting
data through iterative least-squares-type regression. Due to the
tendency of CaMB peptides to aggregate in any salt, we recon-
stituted the CaMB peptides for ITC experiments in a low ionic
strength (10 mM HEPES, pH 7.0, 0.1 mM CaCl2) buffer for all
CaMB peptides. All experiments were performed at 25 °C, with
1000 rpm stirring, 5cal/s reference power, and high-feedback
gain. Injection conditions were typically 1.2–1.8l each (22–28
injections), and cell/syringe concentrations were optimized for
individual experiments (c value between 10 and 1000) (87–89)
but typically between 10 and 50 M for the cell and 100 to 500
M for the syringe. Periodically, water-water and buffer-buffer
controls were conducted to ensure the syringe and cell were
clean and in good working order. Most of the endothermic
titrations had to be baseline-subtracted against the final injec-
tion heats (end-weighted auto-baseline or manual baseline for
Cav3.3 correct for the heat of dilution) due to fitting artifacts
from the isotherm passing through the x axis. Baseline-cor-
rected curves were all fitted to a one-set-of-sites model in Ori-
gin 2017 (OriginLab) software with satisfactory results.
Electronmicroscopy
Full-length mammalian Cav3.1 was expressed in Sf9 insect
cells and purified as described previously (38). Recombinant
human Cav3.1 was incubated (1:1 molar ratio) with biotin–
CaM (Calbiochem) in 1.5mMCaCl2 after which a streptavidin–
gold conjugate (5 nm) was added (38). Samples were examined
using standard negative staining techniques with 2% (w/v) ura-
nyl acetate. Images of the Cav3.1–CaM complexes were
recorded on a Tecnai 12 transmission electron microscope
operated at 100 kV.
NMR
Complex formation of gating brake peptidewithCaM in a 1:1
ratio was monitored by acquiring a 1H-15N heteronuclear sin-
gle-quantum coherence (HSQC) spectrum in a manner previ-
ously publishedwithCaMandpeptides (90).NMRspectrawere
recorded at 25 °C on Bruker 600 and 700MHz DRX spectrom-
eters equipped with XYZ-gradient triple-resonance probes
(Bruker, Billerica, MA), and analyzed with CARA (computer-
aided resonance assignment). CaM for NMR experiments was
expressed inM9minimal media (11.03 g/liter Na2HPO47H2O,
3.0 g/liter KH2PO4, 0.5 g/liter NaCl, 2 mM MgSO4, 0.1 mM
CaCl2, 5 mg/ml thiamine, 100 g/ml kanamycin) containing 2
g/liter [13C]glucose and 1 g/liter 15NH4Cl; 13C-15N CaM was
purified. The samples were prepared for NMR experiments via
a buffer exchange into NMR solution (100 mM KCl, 10 mM
CaCl2, 0.2 mM NaN3, 90% H2O, 10% 2H2O) at pH 6.0 using a
YM10 centrifugal filter device (Millipore, Billerica). All NMR
samples contained 300MCaM in a total volume of 500l. The
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samples were transferred into 5-mm NMR sample tubes and
stored at 4 °C until required for NMR experiments. NMR
experiments on the complexes were conducted on CaM sam-
ples titrated with each peptide to saturation in a 1:1 CaM/pep-
tide ratio. Complex formation was monitored after each addi-
tion by acquisition of a 1H-15N HSQC pulse sequence. NMR
spectra were recorded at 25 °C on Bruker 600 and 700 MHz
DRX spectrometers equipped with XYZ-gradients triple-reso-
nance probes (Bruker, Billerica, MA.). Spectra were analyzed
using the program CARA.
Electrophysiological recordings
Macroscopic currents were recorded at room temperature
using an Axopatch 200B amplifier (Molecular Devices). Boro-
silicate glass pipettes had a resistance of 1.5–2.5 megaohms
when filled with an internal solution containing (in mM): 140
CsCl, 10 EGTA, 10 HEPES, 3 Mg-ATP, 0.6 GTP-Na (pH
adjusted to 7.25 with CsOH, 315 mosM). The extracellular
solution contained (in mM): 145 tetraethylammonium-Cl, 10
HEPES, and 2CaCl2 (pH adjusted to 7.25with tetraethylammo-
nium-OH, 330 mosM). Recordings were filtered at 2 kHz.
Data were analyzed using pCLAMP9 (Molecular Devices),
GraphPad Prism (GraphPad), and Origin 2017 (OriginLab)
software. Current-voltage relationships were generated in 5- or
10-mV voltage steps from a holding potential of 100 mV.
Steady-state inactivation curves were constructed by plotting
normalized peak currents (peak test pulse current/peak pre-
pulse current) as a function of inactivating potentials. Kinetics
of activation and inactivationwere determined by fittingmono-
exponential functions over the growing or decaying phases of
each current trace.
Statistical analyses
Results are presented as mean	 S.E., and n
 the number of
cells. Statistical analysis was first performed with the Student’s
t test or with one-way ANOVA combined with a Tukey post-
test for multiple comparisons (*, p 0.05; **, p 0.01; ***, p
0.001). For the electrophysiology data sets as paired data of
treatment values compared with control values at time 0 and
after 20 min of CaMB peptide dialyses in Figs. 7 and 8, we also
used a non-parametric Wilcoxon matched-pairs signed rank
test. In Fig. 9, there were three sets of data to compare between
wild type, CaM overexpression, and CaM1234 overexpression,
so we used a Kruskal-Wallis test here followed by a Dunn’s
multiple comparison test or a Mann-Whitney test. The statis-
tical analyses using parametric and non-parametric analyses
produced similar results.
Co-immunoprecipitation experiments
Forty eight hours after transfection, cells cultured in 35-mm
dishes were lysed on ice for 20 min with Nonidet P-40 buffer
containing 50 mM Tris-HCl, pH 7.4, 125 mM NaCl, 25 mM
MgCl2, 33.3 M CaCl2, 5% glycerol, 1% Nonidet P-40. Cell
lysates were centrifuged at 10,000 g for 30 min at 4 °C. Clar-
ified cell lysates were then incubatedwith anti-GFP-conjugated
magnetic beads (Thermo Fisher Scientific) for 4 h at 4 °C. The
beadswerewashed four timeswith lysis buffer and resuspended
in 2 loading buffer. The immunoprecipitates were then ana-
lyzed by SDS-PAGE and Western blotting.
Western blotting
Samples were loaded on SDS-PAGE. Proteins were then
transferred onto nitrocellulose membranes and blocked with
5% powdered nonfat milk in PBS-T (Tween 0.1%). Primary
antibody was incubated overnight at 4 °C in 5% powdered non-
fat milk in PBS-T (Tween 0.1%). After three washes in 5% pow-
dered nonfat milk in PBS-T, the secondary HRP-coupled anti-
bodies were incubated for 1 h at room temperature in the same
buffer. The signal was detected using the Super Signal West
Pico chemiluminescent system (Thermo Fisher Scientific).
Antibodies and reagents
The antibodies used in the study were as follows: rat anti-HA
(3F10, RocheApplied Science; 1:1000) and secondary goat anti-
rat antibody coupled to horseradish peroxidase (112-036-072
Jackson ImmunoResearch; 1:5000); rabbit anti-GFP (TP401,
Torrey Pines Biolabs; 1:5000); and secondary donkey anti-rab-
bit coupled to horseradish peroxidase (NA934 GE Healthcare;
1:10,000).
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